A review of the association between antipsychotic use and hyperprolactinaemia.

  title={A review of the association between antipsychotic use and hyperprolactinaemia.},
  author={Chris J P Bushe and Michael Shaw and Robert C. Peveler},
  journal={Journal of psychopharmacology},
  volume={22 2 Suppl},
Recent evidence linking hyperprolactinaemia to longer-term clinical sequelae, including osteoporosis, hip fractures and possibly breast cancer, is increasing clinical awareness of the relevance of hyperprolactinaemia. A review of the literature finds clinical trials reporting some degree of comparative prolactin data among antipsychotics. Many of the randomised clinical trials (RCTs) do not report categorical rates of hyperprolactinaemia in contrast with the naturalistic studies, making it… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
29 Citations
55 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 29 extracted citations


Publications referenced by this paper.
Showing 1-10 of 55 references

The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophrenia

  • DU Jung, YS Sea, +4 authors JC Shim
  • J Clin Psychopharmacol
  • 2005
Highly Influential
2 Excerpts

Similar Papers

Loading similar papers…